Form 4: CareDx Director Peter Maag Sells 10,000 Shares Under Pre-Arranged 10b5-1 Plan
Insider Transaction Report
CareDx, Inc. Director Peter Maag sold 10,000 shares of common stock at a weighted average price of $18.5831 per share on July 7, 2025, pursuant to a Rule 10b5-1 trading plan.
Summary
- Peter Maag, a Director of CareDx, Inc. (CDNA), executed a sale of 10,000 shares of common stock.
- The transaction occurred on July 7, 2025.
- The shares were sold at a weighted average price of $18.5831 per share, with individual sales ranging from $18.40 to $18.86 per share.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Maag on August 21, 2024.
- Following this transaction, Peter Maag beneficially owns 308,846 shares of CareDx, Inc. common stock.
Sentiment
Score: 4
Explanation: The sale of shares by a director, while executed under a pre-arranged plan (mitigating the negative signal), is generally perceived as neutral to slightly negative by the market, as it represents an insider reducing their stake.
Negatives
- A director selling shares, even under a pre-arranged plan, can be perceived by some investors as a signal of reduced confidence in the company's future prospects or that the stock is fully valued.
Future Outlook
No forward-looking statements or guidance are provided in this document, as it is a report of a past insider transaction.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders may interpret the director's sale as a potential lack of confidence, which could lead to negative sentiment or downward pressure on the stock price.
Next Steps
- The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.
Key Dates
| Date | Description |
|---|---|
| August 21, 2024 | Date the Rule 10b5-1 trading plan was adopted by Peter Maag. |
| July 7, 2025 | Date of the reported transaction (sale of common stock). |
| July 10, 2025 | Date the Form 4 was signed by Peter Maag. |
Keywords
CareDx, CDNA, Form 4, Insider Trading, Stock Sale, Peter Maag, Director, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.